Download Presentation
DRI Healthcare to Host Second Quarter 2025 Earnings Call and Webcast on August 14, 2025
DRI Healthcare Comments on FDA Approval and our Increased Investment in KalVista Pharmaceuticals' Ekterly® (sebetrals...
DRI Healthcare Announces Closing of Internalization Transaction